Biopharma Co. Seelos Gets OK For $22M Ch. 11 Sale
By Rick Archer · September 17, 2025, 12:24 PM EDT
A New York bankruptcy judge on Wednesday approved the $22 million credit bid sale of bankrupt biopharmaceutical company Seelos Therapeutics after hearing the buyer had agreed to add another $100,000 in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login